UPDATE - IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
28 juil. 2022 13h57 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., July 28, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market...
IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
22 juil. 2022 16h30 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., July 22, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market...
IRADIMED Names John F. Glenn Chief Financial Officer
26 mai 2022 16h05 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., May 26, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John (Jack) Glenn has been appointed Chief Financial Officer effective on or before...
IRADIMED CORPORATION Announces First Quarter 2022 Financial Results
29 avr. 2022 07h00 HE
|
iRadimed Corporation
Reports first quarter 2022 revenue of $12.3 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.22Announces second quarter 2022 financial guidanceIncreases full-year 2022 financial...
IRADIMED CORPORATION Announces Executive Transition
28 avr. 2022 16h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today announced that Chris Scott, Chief Financial and Operating Officer, has...
IRADIMED CORPORATION to Hold 2022 First Quarter Financial Results Conference Call on April 29th
05 avr. 2022 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 05, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 first quarter financial results before the market...
IRADIMED Announces Special $1.00 Per Share Cash Dividend
07 févr. 2022 16h05 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Feb. 07, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors approved a special cash dividend of $1.00 per share...
IRADIMED CORPORATION Announces Fourth Quarter 2021 Financial Results
04 févr. 2022 07h00 HE
|
iRadimed Corporation
Reports fourth quarter 2021 revenue of $11.9 million, GAAP diluted EPS of $0.31 and non-GAAP diluted EPS of $0.33Announces full-year and first quarter 2022 financial guidance WINTER SPRINGS, Fla.,...
IRADIMED CORPORATION to Hold 2021 Fourth Quarter Financial Results Conference Call on February 4th
20 janv. 2022 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Jan. 20, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 fourth quarter financial results before the market...
IRADIMED CORPORATION Announces Third Quarter 2021 Financial Results
29 oct. 2021 07h00 HE
|
iRadimed Corporation
Reports third quarter 2021 revenue of $10.9 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23Increases full-year 2021 financial guidance WINTER SPRINGS, Fla., Oct. 29,...